Do ketamine infusions work for CRPS?

Ketamine infusions reduce complex regional pain syndrome (CRPS) pain for many people in the short term. A 2026 meta-analysis of 21 studies and 605 patients found that pain fell by an average of 3.6 points on a 10-point scale within two weeks and drifted back toward baseline by 90 days. Ketamine has no FDA-approved pain indication.

A painted apothecary bottle and mortar with a poppy and lupine.

What is a ketamine infusion for CRPS?

A ketamine infusion for complex regional pain syndrome is a slow intravenous dose of the anesthetic ketamine, given at doses below those used for anesthesia. Ketamine blocks the NMDA receptor, a nerve cell receptor involved in the amplification of pain signals in the spinal cord and brain. The 2022 practical guidelines in Pain Medicine say the positive ketamine trials point to this amplification, called central sensitization, in CRPS.

The same guidelines note that ketamine has also been given by mouth, by nasal spray and on the skin. The CRPS trials described on this page tested intravenous infusions only.

What did the randomized trials of ketamine for CRPS find?

Two randomized, placebo-controlled trials published in 2009 found that ketamine infusions reduced CRPS pain. Sigtermans and colleagues gave 60 patients with CRPS type I, whose median disease duration was 7.4 years, a 4.2-day continuous infusion of ketamine or placebo. At the end of the first week, pain averaged 2.68 on a 0 to 10 scale with ketamine and 5.45 with placebo.

Schwartzman and colleagues tested outpatient ketamine infusions for CRPS, given for four hours a day for ten days. The ketamine group had statistically significant reductions in many pain measures, and the placebo group showed no treatment effect. The authors wrote that the results "warrant a larger randomized placebo controlled trial."

How long does pain relief from a ketamine infusion last?

Pain relief from ketamine infusions for CRPS has lasted weeks to a few months in the published studies. In Sigtermans' 2009 trial, the difference between ketamine and placebo was no longer significant at week 12. A 2018 meta-analysis by Zhao and colleagues found that 69 percent of patients had at least 30 percent pain relief immediately after treatment and 58 percent at one to three months.

A 2026 meta-analysis by van den Brink and colleagues pooled 21 studies, three of them randomized trials, with 605 patients treated with ketamine for CRPS. From an average starting pain score of 7.4, pain changed by -3.6 points within 14 days. The longer-term data, which the authors called limited, "suggested attenuation of effect, with a gradual return toward baseline" by 90 days.

Which studies of ketamine for CRPS carry the most weight?

Two randomized trials and two meta-analyses carry most of the evidence on ketamine infusions for CRPS. Only 3 of the 21 studies in the 2026 meta-analysis were randomized trials.

Trials and meta-analyses of intravenous ketamine for CRPS
StudyWho was studiedWhat the study found
Sigtermans et al., Pain, 2009 (randomized trial)60 patients with CRPS type I; 4.2-day ketamine infusion or placeboPain at week 1 was 2.68 with ketamine and 5.45 with placebo; no significant difference by week 12
Schwartzman et al., Pain, 2009 (randomized trial)Outpatients with CRPS; ketamine or placebo for 4 hours daily for 10 daysSignificant reductions in many pain measures with ketamine; no treatment effect with placebo
Zhao et al., 2018 (meta-analysis)Trials and cohort studies of ketamine for CRPS through 201769 percent had pain relief immediately and 58 percent at 1 to 3 months; high heterogeneity and publication bias
van den Brink et al., The Journal of Pain, 2026 (meta-analysis)21 studies, 605 patients given ketamine for CRPSPain changed by -3.6 points on a 0 to 10 scale within 14 days; gradual return toward baseline by 90 days

Does ketamine improve function in CRPS, or only pain?

The trial that measured function found no improvement. Sigtermans and colleagues reported in 2009 that in patients with mostly chronic CRPS type I, "a multiple day ketamine infusion resulted in significant pain relief without functional improvement." Guidelines describe pain treatments as a way to make rehabilitation possible. The therapies that aim at function are described in physical and occupational therapy for CRPS.

What are the side effects of ketamine infusions?

Ketamine infusions commonly cause temporary mental side effects. In Sigtermans' 2009 trial, 76 percent of CRPS patients given ketamine had mild to moderate psychomimetic effects, such as altered perception, compared with 18 percent given placebo. The 2022 practical guidelines list dysphoria, hallucinations and a drug "high" and say these effects make the treatment unattractive to many patients.

A 2022 article in ASRA Pain Medicine News describes dose-dependent rises in blood pressure and heart rate with ketamine. The article says ketamine is unsuitable for people with uncontrolled hypertension, unstable angina, raised pressure in the eye or skull, severe liver disease, or a history of psychosis or substance abuse. The article reports that more than 95 percent of side effects are transient.

What do guidelines say about ketamine for CRPS?

Guidelines give ketamine for CRPS cautious support. The 2018 consensus guidelines of three United States anesthesia and pain societies, led by Cohen, concluded that "evidence supports the use of ketamine for chronic pain, but the level of evidence varies by condition and dose range," and that most studies were small and poorly blinded. A 2022 ASRA article summarized the CRPS evidence as "medium-term improvement (moderate evidence)."

The 2022 practical guidelines for CRPS observe that low-dose ketamine infusions are increasingly provided at some centers "in the absence of respectable long-term outcomes data." The National Institute of Neurological Disorders and Stroke lists ketamine among exploratory treatments for CRPS.

Is ketamine approved by the FDA for CRPS?

Ketamine is not approved by the Food and Drug Administration for CRPS or for any pain condition. The 2022 article in ASRA Pain Medicine News states, "Currently, there is no FDA-approved indication for using ketamine infusion as a treatment modality," and that ketamine is approved "for the induction and maintenance of anesthesia." Use for CRPS is off label. The article adds that ketamine is a Schedule III controlled substance under federal law.

Which ketamine dosing schedules were studied for CRPS?

Two ketamine schedules have randomized trial support in CRPS. The inpatient schedule from Sigtermans' trial is a continuous infusion over about four days, which reached 22.2 mg per hour for a 70 kg person by the end. The outpatient schedule from Schwartzman's trial is a four-hour infusion on ten days, at no more than 0.35 mg per kg per hour.

The 2022 ASRA article notes that there is "no single consensus or guideline on the infusion dosage or the number of infusion treatments needed." Clinics vary, and the schedule for a person with CRPS is set by the treating physician.

How much does a ketamine infusion cost?

A 2022 article in ASRA Pain Medicine News reported that "the average cost to the patient is anywhere between $415-$1,350 per infusion session," depending on the length of the infusion and the dose. A CRPS course involves several sessions. Ten sessions at those prices would total $4,150 to $13,500, which is this site's arithmetic and not a published figure. Prices vary by clinic and region, and the 2022 range has not been updated. See what CRPS treatment costs.

Does insurance cover ketamine infusions for CRPS?

Coverage of ketamine infusions for CRPS is limited. The 2022 article in ASRA Pain Medicine News stated, "Neither federal nor private medical insurance providers cover the cost of ketamine infusion therapy for any disorders. Patients must pay out of pocket for treatment." That statement is from 2022 and is absolute, and individual plans may differ now. Whether a particular plan covers ketamine infusion for chronic pain is set out in that plan's written medical policy.

What about oral ketamine and the ketamine coma?

Neither oral ketamine nor anesthetic-dose ketamine is supported for CRPS by the 2022 practical guidelines. The guidelines state, "There is no clinical trial evidence-base supporting treatment with oral Ketamine." The guidelines say that high-dose "ketamine coma," in which a patient is kept under anesthesia for days, "is likely associated with very serious side effects and cannot be recommended."

Can the cost of ketamine be part of a California injury claim?

The cost of ketamine infusions can be claimed in a California injury case if the legal standard for medical expenses is met. The Judicial Council's jury instruction CACI No. 3903A requires proof of "the reasonable cost of reasonably necessary medical care" already received and of care the person "is reasonably certain to need in the future." Insurers commonly argue that an off-label treatment with short-term evidence does not meet that standard, so the treating physician's records of response to each infusion matter. See the CRPS life care plan.

Common questions

The two randomized trials used different schedules. Sigtermans' 2009 trial gave one continuous infusion lasting 4.2 days in hospital. Schwartzman's 2009 trial gave a four-hour outpatient infusion on ten days. A 2022 ASRA Pain Medicine News article states that there is no single consensus or guideline on the number of infusion treatments needed. The long-term results of repeated infusions have not been established in trials.

No study shows that ketamine cures CRPS. In the published studies, pain relief faded over weeks to months: a 2026 meta-analysis of 21 studies described a gradual return toward baseline by 90 days. The 2022 practical guidelines in Pain Medicine state that the available drugs for CRPS are not thought to cure the condition, and the Royal College of Physicians' 2018 guideline states that there is no proven cure.

It can. The authors of the 2022 practical guidelines in Pain Medicine report that in their own clinical experience, which they rate as level 4 evidence, tolerance to ketamine treatment can develop and shortens the period of full benefit. The 2018 consensus guidelines on ketamine for chronic pain called for larger studies to develop a greater understanding of the long-term risks of repeated treatments.

Researchers cannot yet predict it. The 2026 meta-analysis by van den Brink and colleagues found that definitions of a responder varied widely across studies, with a median responder rate of 65 percent and a range from 0 to 100 percent. Only three studies formally tested predictors of response. The authors concluded that the limited evidence "precludes firm conclusions for individualized treatment selection."

Ketamine infusions are given in a hospital or a monitored clinic. A 2022 ASRA Pain Medicine News article says sessions must take place in a clinic setting with vital sign monitoring and a physician able to manage the airway on call or nearby. The article recommends monitoring of heart rate, blood pressure, oxygen level and level of consciousness during the infusion.

A 2024 systematic review by Zhu and colleagues compared drug treatments across 23 randomized trials with 1,029 patients with CRPS. Ketamine and bisphosphonates ranked highest for pain relief, and both produced more adverse events than placebo, which the review described as mild. The certainty of the ketamine evidence was rated low. The trials in the review compared each drug with placebo, not with one another. Other drug classes are described in medications for CRPS.

ClinicalTrials.gov, the registry run by the National Library of Medicine, lists CRPS studies and their recruiting sites. The California CRPS trial finder on this site reads that registry and shows studies with California locations, including any that involve ketamine. The study team and the person's own doctor decide whether a study is suitable.

Sources

Every source below was opened and read for this page. The date is when it was last checked.

  1. Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1Study · Pain (Sigtermans et al.), 2009 · checked
  2. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled studyStudy · Pain (Schwartzman et al.), 2009 · checked
  3. The Effect of Ketamine Infusion in the Treatment of Complex Regional Pain Syndrome: a Systemic Review and Meta-analysisStudy · Current Pain and Headache Reports (Zhao et al.), 2018 · checked
  4. Intravenous ketamine for complex regional pain syndrome: Pain outcomes and predictors of response. A systematic review and meta-analysisStudy · The Journal of Pain (van den Brink et al.), 2026 · checked
  5. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of AnesthesiologistsClinical guideline · Regional Anesthesia and Pain Medicine (Cohen et al.), 2018 · checked
  6. Ketamine Infusion Therapy and Its Role in Chronic PainOrganization · ASRA Pain Medicine News (Goordeen et al.), 2022 · checked
  7. Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th EditionClinical guideline · Pain Medicine (Harden et al.), 2022 · checked
  8. Complex regional pain syndrome in adults: UK guidelines for diagnosis, referral and management in primary and secondary care, 2nd editionClinical guideline · Royal College of Physicians, 2018 · checked
  9. Complex Regional Pain SyndromeGovernment agency · National Institute of Neurological Disorders and Stroke · checked
  10. Efficacy and Safety of Pharmacological Treatment in Patients with Complex Regional Pain Syndrome: A Systematic Review and Meta-AnalysisStudy · Pharmaceuticals (Zhu et al.), 2024 · checked
  11. Judicial Council of California Civil Jury Instructions (CACI), 2026 editionJury instruction · Judicial Council of California, 2026 · checked
  12. ClinicalTrials.gov study registry and APIDataset · U.S. National Library of Medicine · checked

Ask a lawyer about your CRPS case

Free case review. No fee unless we recover. A person from Wise Law reads every message.

What happened before the CRPS started? (optional)
Has a doctor diagnosed CRPS? (optional)
Or call (424) 235-7879

Submitting this form does not create an attorney-client relationship. An attorney-client relationship is formed only by a signed written fee agreement.

Text usCall